US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.730
  • -0.110-2.86%
Close Nov 22 16:00 ET
  • 3.740
  • +0.010+0.27%
Post 20:01 ET
391.29MMarket Cap-1942P/E (TTM)

Revance Therapeutics Key Stats

Revance Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 69.300M --
-- 2024/Q4 -- / 83.350M --
-- 2024/Q3 59.879M / 68.175M --
Aug 8, 2024 2024/Q2 65.389M / 66.290M --
May 9, 2024 2024/Q1 51.936M / 56.658M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 69.300M--
--2024/Q4-- / 83.350M--
--2024/Q359.879M / 68.175M--
Aug 8, 20242024/Q265.389M / 66.290M--
May 9, 20242024/Q151.936M / 56.658M--

Unlock Free Earnings Estimates

Revance Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Nov 12, 2024

Hold

  • Buy

    0.00%
  • Hold

    100.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data